ENTITY

Ultragenyx Pharmaceutical (RARE US)

9
Analysis
Health Care • United States
Ultragenyx Pharmaceutical Inc. provides biotechnology services. The Company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. Ultragenyx Pharmaceutical conducts its business in the United States.
more
Company Event • 04 Nov 2026 06:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 18 Sep 2026 05:30 • Latest

FDA announcement

Company Event • 19 Aug 2026 19:00

Status update

Company Event • 05 Aug 2026 05:00

Q2 2026

Company Event • 10 Jun 2026 04:00

Goldman Sachs 47th Annual Global Healthcare Conference 2026

x